Renaissance Technologies
DPLO

Renaissance Technologies’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Renaissance Technologies’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,550,960
Closed -$10.2M – 4002
2019
Q4 		$10.2M Buy
2,550,960
+2,346,060
+1,145% +$11M 0.01% 1432
2019
Q3 		$1M Buy
204,900
+58,100
+40% +$325K ﹤0.01% 2591
2019
Q2 		$894K Buy
146,800
+87,800
+149% +$467K ﹤0.01% 2730
2019
Q1 		$343K Buy
+59,000
New +$609K ﹤0.01% 3051
2017
Q3 		– Sell
-33,100
Closed -$490K – 3461
2017
Q2 		$490K Buy
33,100
+5,200
+19% +$86.7K ﹤0.01% 2775
2017
Q1 		$445K Sell
27,900
-311,600
-92% -$4.49M ﹤0.01% 2803
2016
Q4 		$4.28M Buy
+339,500
New +$6.32M 0.01% 1769
2015
Q4 		– Sell
-175,500
Closed -$5.04M – 3508
2015
Q3 		$5.04M Buy
+175,500
New +$7.5M 0.01% 1391

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Renaissance Technologies's DPLO Position: Q1 2020 in Review

Renaissance Technologies sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 2,550,960 shares — an estimated $10.2M sold.

Renaissance Technologies first reported a position in DPLO in Q3 2015 and held it in 8 quarters. The position peaked at $10.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Renaissance Technologies reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Renaissance Technologies sold 2,550,960 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $10.2M.
  • Renaissance Technologies first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 8 quarters.
  • Renaissance Technologies's DIPLOMAT PHARMACY, INC. position peaked at $10.2M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.